Bionano shares overview of agbt pre-conference workshop program along with details of company's innovative research grant opportunity
San diego, feb. 14, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced details of topics covered at the company's pre-conference workshop during the advances in genome biology and technology (agbt) 2023 general meeting, which took place february 6-9, 2023 in hollywood, florida. bionano leaders alka chaubey, phd, facmg, chief medical officer, alex hastie, phd, vice president of clinical and scientific affairs, marc meyers, head of product management, and klint rose, phd, fellow, itp technology development, delivered presentations on optical genome mapping (ogm) and its potential to replace traditional cytogenetic methods for structural variant (sv) detection, as well as an overview of the company's new product advancements. damla senol cali, phd, staff software engineer, hardware acceleration at bionano and george vacek, phd, global head of genomics alliances at nvidia previewed the companies' collaborative development, a next-generation compute solution for the analysis of ogm data from high throughput systems. sheila purim, phd, mba, senior director of segment marketing, announced the bionano innovator research grant, which will award five winners with ogm technology designed to fuel research in a number of areas, including hematologic malignancies, cell therapy, reproductive health and precision medicine. adam smith, phd, fccmg, facmg, erclg from university health network, university of toronto, presented on use of the via software in his clinical research, and alexander hoischen, phd, from radboud genomics technology center presented on use of ogm for sv detection in rare disease research. bionano and nvidia presenters, along with drs. smith and hoischen, also participated in live q&a sessions with the audience.
